[HTML][HTML] Mitophagy in hepatic insulin resistance: therapeutic potential and concerns
Z Su, Y Nie, X Huang, Y Zhu, B Feng, L Tang… - Frontiers in …, 2019 - frontiersin.org
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia,
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Z Su, Y Nie, X Huang, Y Zhu, B Feng… - … Factors in Liver and …, 2020 - books.google.com
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia,
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns.
Z Su, Y Nie, X Huang, Y Zhu, B Feng… - Frontiers in …, 2019 - europepmc.org
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia,
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
[引用][C] Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Z Su, Y Nie, X Huang, Y Zhu, B Feng… - … in Pharmacology (Web …, 2019 - jglobal.jst.go.jp
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns | Article
Information | J-GLOBAL Art J-GLOBAL ID:201902217751717258 Reference number:19A2654465 …
Information | J-GLOBAL Art J-GLOBAL ID:201902217751717258 Reference number:19A2654465 …
[HTML][HTML] Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Z Su, Y Nie, X Huang, Y Zhu, B Feng… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia,
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Z Su, Y Nie, X Huang, Y Zhu, B Feng… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia,
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …
increases the morbidity and mortality of cardiovascular disease, type 2 diabetes …